chr3-190399701-T-A

Position:

• chr3-190399701-T-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_006580.4(CLDN16):​c.115-2636T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.798 in 152,032 control chromosomes in the GnomAD database, including 48,554 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.80 (48554 hom., cov: 30)
• Consequence: CLDN16 NM_006580.4 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.302

Genes affected

CLDN16 (HGNC:2037): (claudin 16) Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. The protein encoded by this gene, a member of the claudin family, is an integral membrane protein and a component of tight junction strands. It is found primarily in the kidneys, specifically in the thick ascending limb of Henle, where it acts as either an intercellular pore or ion concentration sensor to regulate the paracellular resorption of magnesium ions. Defects in this gene are a cause of primary hypomagnesemia, which is characterized by massive renal magnesium wasting with hypomagnesemia and hypercalciuria, resulting in nephrocalcinosis and renal failure. This gene and the CLDN1 gene are clustered on chromosome 3q28. [provided by RefSeq, Jun 2010]

ACMG classification

Verdict is Benign. Variant got -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.89).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.867 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
CLDN16	NM_006580.4	c.115-2636T>A		intron_variant		ENST00000264734.3
CLDN16	NM_001378492.1	c.115-2636T>A		intron_variant
CLDN16	NM_001378493.1	c.115-2636T>A		intron_variant
CLDN16	XM_047447333.1	c.115-2636T>A		intron_variant

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
CLDN16	ENST00000264734.3	c.115-2636T>A		intron_variant		1	NM_006580.4	P1
CLDN16	ENST00000456423.2	c.115-10202T>A		intron_variant		1
CLDN16	ENST00000468220.1	n.307-2636T>A		intron_variant, non_coding_transcript_variant		4

Frequencies

GnomAD3 genomes AF: 0.798 AC: 121263 AN: 151914 Hom.: 48530 Cov.: 30

Gnomad AFR AF: 0.840

Gnomad AMI AF: 0.803

Gnomad AMR AF: 0.795

Gnomad ASJ AF: 0.754

Gnomad EAS AF: 0.888

Gnomad SAS AF: 0.729

Gnomad FIN AF: 0.805

Gnomad MID AF: 0.744

Gnomad NFE AF: 0.774

Gnomad OTH AF: 0.787

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.798 AC: 121338 AN: 152032 Hom.: 48554 Cov.: 30 AF XY: 0.798 AC XY: 59289 AN XY: 74304

Gnomad4 AFR AF: 0.839

Gnomad4 AMR AF: 0.795

Gnomad4 ASJ AF: 0.754

Gnomad4 EAS AF: 0.889

Gnomad4 SAS AF: 0.729

Gnomad4 FIN AF: 0.805

Gnomad4 NFE AF: 0.774

Gnomad4 OTH AF: 0.782

Alfa AF: 0.772 Hom.: 5658

Bravo AF: 0.803

Asia WGS AF: 0.791 AC: 2754 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.89
CADD	Benign	2.4
DANN	Benign	0.70

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs7625694; hg19: chr3-190117490;